Evidence map›Paper›PMID 26364200›Full record

ReviewJournal of industrial microbiology & biotechnology2016

Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.

Richard H Baltz

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 166 citations in OpenAlex.

  1. Review
  2. Enhancement of Acarbose Production inJournal of agricultural and food chemistry · 2025
    Article
  3. Current Approaches for Genetic Manipulation ofBiotech (Basel (Switzerland)) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CRISPR/Cas9-mediated genome editing in vancomycin-producing strainFrontiers in bioengineering and biotechnology · 2023
    Article
  12. Article
  13. Article
  14. Genome mining for drug discovery: progress at the front end.Journal of industrial microbiology & biotechnology · 2021
    Review
  15. Enhanced Oxytetracycline Production byMolecules (Basel, Switzerland) · 2021
    Article
  16. Review
  17. Genome mining for drug discovery: cyclic lipopeptides related to daptomycin.Journal of industrial microbiology & biotechnology · 2021
    Article
  18. Article
  19. Article
  20. Recent Advances in Silent Gene Cluster Activation inFrontiers in bioengineering and biotechnology · 2021
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Richard H BaltzCognoGen Biotechnology Consulting, 7636 Andora Drive, Sarasota, FL, 34238, USA. rbaltz923@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinomycetes continue to be important sources for the discovery of secondary metabolites for applications in human medicine, animal health, and crop protection. With the maturation of actinomycete genome mining as a robust approach to identify new and novel cryptic secondary metabolite gene clusters, it is critical to continue developing methods to activate and enhance secondary metabolite biosynthesis for discovery, development, and large-scale manufacturing. This review covers recent reports on promising new approaches and further validations or technical improvements of existing approaches to strain improvement applicable to a wide range of Streptomyces species and other actinomycetes.

Indexed as

ActinobacteriaAnimalsBiosynthetic PathwaysGenome, BacterialHumansMultigene FamilySecondary MetabolismStreptomycesActinomyceteChemical mutagenesisGenome miningHeterologous expressionRegulatory genesRibosome engineeringRNA polymeraseSecondary metabolitesStreptomycesSynthetic biologyTransposon mutagenesis

Identifiers

PMID26364200
OpenAlexW2467031173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.